Spine

Lanx names new CEO ― again

For the second time this year, Lanx Inc., a Broomfield-based medical-device company, has named a new CEO from Minnesota.

This time it’s Dan Gladney, a med-tech veteran.

Gladney, whose appointment was announced this week, most recently served as healthcare operating partner at Norwest Equity Partners, a Minneapolis-based private-equity firm.

He was formerly CEO of Heart Leaflet Technologies, which was sold to Bracco Group earlier this year. In addition, he co-founded Acist Medical Systems (also sold to Bracco) and was chairman of Minnetonka, Minn.-based DGIMed Ortho.

Back in June, Lanx announced Michael DeMane, former COO of Medtronic Inc., was its new chairman and CEO, saying at the time that co-founder and former CEO Michael Fulton was becoming its chief technology officer.

But a few weeks later, the company said DeMane “declined to assume the role” and instead would “assist the company as a consultant.”

A Lanx official couldn’t be reached for comment.

Lanx focuses on developing and commercializing devices for spinal surgery.

Read more: Lanx names new CEO ― again | Denver Business Journal

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button